Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2635-2639

  Kato, Hiroyuki ^a   T́akita, Junko ^a   Miyazaki, Tatsuya ^a   Nakajima, Masanobu ^a   Fukai, Yasuyuki ^a   Masuda, Norihiro ^a   Fukuchi, Minoru ^a   Manda, Ryokuhei ^a   Ojima, Hitoshi ^a   Tsukada, Katsuhiko ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Esophageal carcinoma; Glucose transporter 1; Immunohistochemistry; Prognostic value

Indexed keywords

GLUCOSE TRANSPORTER 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DISEASE MARKER; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036766021     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1967.
2. Hatanaka M: Transport of sugars in tumor cell membranes. Biochim Biophys Acta 355: 77-104, 1974.
3. Burant CF, Sivitz WI, Fukumoto H, Kayano T, Nagamatsu S, Seino S, Pessin JE and Bell GI: Mammalian glucose transporters: structure and molecular regulation. Recent Prog Horm Res 47: 349-87; discussion 387-8, 1991.
4. Mueckler M: Facilitative glucose transporters. Eur J Biochem 219: 713-25, 1994.
5. Pardridge WM, Boado RJ and Farrell CR: Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative Western blotting and in situ hybridization. J Biol Chem 265: 18035-40, 1990.
6. Younes M, Lechago LV and Lechago J: Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin Cancer Res 2: 1151-4, 1996.
7. Mellanen P, Minn H, Grenman R and Harkonen P: Expression of glucose transporters in head-and-neck tumors. Int J Cancer 56: 622-9, 1994.
8. Reisser C, Eichhorn K, Herold-Mende C, Born AI and Bannasch P: Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int J Cancer 80: 194-8, 1999.
9. Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, Yamada Y, Inoue K, Manabe T and Imura H: Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 170: 223-30, 1990.
10. Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, Honma K and Suzuki T: Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer 92: 634-41, 2001.
11. Haber RS, Rathan A, Weiser KR, Pritsker A, Itzkowitz SH, Bodian C, Slater G, Weiss A and Burstein DE: GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83: 34-40, 1998.
12. Sakashita M, Aoyama N, Minami R, Maekawa S, Kuroda K, Shirasaka D, Ichihara T, Kuroda Y, Maeda S and Kasuga M: Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features. Eur J Cancer 37: 204-9, 2001.
13. Brown RS and Wahl RL: Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 72: 2979-85, 1993.
14. Younes M, Brown RW, Mody DR, Fernandez L and Laucirica R: GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res 15: 2895-8, 1995.
15. Cantuaria G, Magalhaes A, Penalver M, Angioli R, Braunschweiger P, Gomez-Marin O, Kanhoush R, Gomez-Fernandez C and Nadji M: Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary. Gynecol Oncol 79: 33-7, 2000.
16. Cantuaria G, Fagotti A, Ferrandina G, Magalhaes A, Nadji M, Angioli R, Penalver M, Mancuso S and Scambia G: GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer 92: 1144-50, 2001.
17. Nagase Y, Takata K, Moriyama N, Aso Y, Murakami T and Hirano H: Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol 153: 798-801, 1995.
18. Su TS, Tsai TF, Chi CW, Han SH and Chou CK: Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinoma. Hepatology 11: 118-22, 1990.
19. Younes M, Brown RW, Stephenson M, Gondo M and Cagle PT: Overexpression of Glut1 and Glut3 in stage I non-small cell lung carcinoma is associated with poor survival. Cancer 80: 1046-51, 1997.
20. Younes M, Juarez D, Lechago LV and Lerner SP: Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res 21: 575-8, 2001.
21. Younes M, Lechago J, Chakraborty S, Ostrowski M, Bridges M, Meriano F, Solcher D, Barroso A, Whitman D, Schwartz J, Johnson C, Schmulen AC, Verm R, Balsaver A, Carlson N and Ertant A: Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia. Scand J Gastroenterol 35: 131-7, 2000.
22. Younes M, Pathak M, Finnie D, Sifers RN, Liu Y and Schwartz MR: Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas. Anticancer Res 20: 3775-9, 2000.
23. Kuwano H, Saeki H, Kawaguchi H, Sonoda K, Kitamura K, Nakashima H et al. Proliferative activity of cancer cells in front and center areas of carcinoma in situ and invasive sites of esophageal squamous cell carcinoma. Int J Cancer 78: 149-52, 1998.
24. Wang BY, Kalir T, Sabo E, Sherman DE, Cohen C and Burstein DE: Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Cancer 88: 2774-81, 2000.
25. Noguchi Y, Saito A, Miyagi Y, Yamanaka S, Marat D, Doi C, Yoshikawa T, Tsuburaya A, Ito T and Satoh S: Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth. Cancer Lett 54: 175-82, 2000.